TrialBMJ (Clinical research ed.)2025

Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial.

Yuan Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.